A Study of the TAXUS Liberté Stent for the Treatment of Long De Novo Coronary Artery Lesions

PHASE3CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

February 28, 2007

Study Completion Date

May 31, 2011

Conditions
Coronary Artery Disease
Interventions
DEVICE

TAXUS Liberté-SR

Paclitaxel-Eluting Coronary 38 mm Stent

DEVICE

TAXUS™ Express

Paclitaxel-Eluting Coronary Stent System

Trial Locations (25)

1003

Mercy Angiography Unit, 98 Mountain Road, First Floor, Auckland

1023

Auckland City Hospital, Auckland

8001

Christchurch Hospital, Christchurch

10032

Columbia University Medical Center, New York

20912

Washington Adventist Hospital, Takoma Park

27610

Wake Medical Center, Raleigh

32803

Florida Hospital, Orlando

37660

Wellmont Holston Valley Medical Center, Kingsport

38801

North Mississippi Medical Center, Tupelo

43214

Riverside Methodist Hospital, Columbus

44035

North Ohio Research Elyria Memorial Hospital, Elyria

46290

The Heart Center, Indianapolis

49770

Northern Michigan Hospital, Petoskey

55805

St. Mary's Duluth Clinic Regional Heart Center, Duluth

62701

St. John's Hospital, Springfield

73120

Oklahoma Foundation for Cardiovascular Research, Oklahoma City

76508

Scott & White Memorial Hospital, Temple

95819

Mercy General Hospital, Sacramento

168752

National Heart Centre, Singapore

19718-0002

Christiana Hospital, Newark

04102

Maine Medical Center, Portland

17033-0850

The Pennsylvania State University Milton S Hershey Medical Center, Hershey

77030-2767

Methodist DeBakey Heart Center, Houston

Unknown

Dunedin Hospital, Dunedin

National University Hospital, Singapore

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY